help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Todd, R.
Right arrow Articles by Wong, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Todd, R.
Right arrow Articles by Wong, D. T.

American Journal of Pathology, Vol 138, 1307-1313, Copyright © 1991 by American Society for Investigative Pathology


REGULAR ARTICLES

The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds

R Todd, BR Donoff, T Chiang, MY Chou, A Elovic, GT Gallagher and DT Wong
Department of Oral Medicine and Oral Pathology, Harvard School of Dental Medicine, Boston, MA 02115.

Epidermal growth factor (EGF) and transforming growth factor-alpha (TGF- alpha) are known to promote the healing of epithelial wounds. Eosinophils are present in healing wounds and have recently been shown to be capable of producing TGF-alpha. This investigation was done to determine if eosinophils infiltrated into healing wounds are capable of expressing this cytokine. Using the rabbit cutaneous open wound model, the study found that the eosinophil is one of the predominant cell types in the healing wound, beginning from the seventh day and thereafter. Most surprisingly, the majority of the eosinophils present in the healing wound were found to contain TGF-alpha mRNA and protein by in situ hybridization and immunohistochemistry. Thus it is proposed that the delivery of TGF-alpha by eosinophils to epithelial wound healing sites represents a normal body mechanism whereby this multifunctional cytokine can accelerate the wound healing process.


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. Wehling-Henricks, S. Sokolow, J. J. Lee, K. H. Myung, S. A. Villalta, and J. G. Tidball
Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy
Hum. Mol. Genet., August 1, 2008; 17(15): 2280 - 2292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Samoszuk, T. Deng, M. J. Hamamura, M.-Y. Su, N. Asbrock, and O. Nalcioglu
Increased Blood Clotting, Microvascular Density, and Inflammation in Eotaxin-Secreting Tumors Implanted into Mice
Am. J. Pathol., August 1, 2004; 165(2): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. WERNER and R. GROSE
Regulation of Wound Healing by Growth Factors and Cytokines
Physiol Rev, July 1, 2003; 83(3): 835 - 870.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. N. Sferruzzi-Perri, S. A. Robertson, and L. A. Dent
Interleukin-5 Transgene Expression and Eosinophilia Are Associated with Retarded Mammary Gland Development in Mice
Biol Reprod, July 1, 2003; 69(1): 224 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Phipps, S. Ying, A. Wangoo, Y.-E. Ong, F. Levi-Schaffer, and A. B. Kay
The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin
J. Immunol., October 15, 2002; 169(8): 4604 - 4612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-D. Beer, C. Munding, N. Dubois, C. Mamie, D. Hohl, and S. Werner
The Estrogen-responsive B Box Protein. A NOVEL REGULATOR OF KERATINOCYTE DIFFERENTIATION
J. Biol. Chem., May 31, 2002; 277(23): 20740 - 20749.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Hao, D. A. Cohen, C. D. Jennings, J. S. Bryson, and A. M. Kaplan
Bleomycin-induced pulmonary fibrosis is independent of eosinophils
J. Leukoc. Biol., October 1, 2000; 68(4): 515 - 521.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Q. Yuan, K. F. Austen, D. S. Friend, M. Heidtman, and J. A. Boyce
Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)-mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1)
J. Exp. Med., July 21, 1997; 186(2): 313 - 323.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.